Abstract
Background: Despite the progressive improvement in current treatment, one fourth of children with acute lymphoblastic leukemia (ALL) still relapse and endure dismal prognosis. In the present study, we introduce more evidence of the antiproliferative effects of 3-[(dodecylthiocarbonyl)-methyl]- glutarimide (DTCM-g), a novel synthetic derivative of 9-methylstreptimidone, on four childhood ALL derived cell lines.
Methods: REH, NALM-6, MOLT4 and Jurkat cell lines were treated with varied doses of DTCM-g (2.5 to 20ug/mL) and analyzed in terms of growth (Resazurin reduction), apoptosis (caspase-activation) and cell cycle dynamics. The impact on drug interactions in simultaneous treatments with vincristine, methotrexate and 6-mercaptopurine was also investigated. Results: Our results showed statistically significant reductions in growth in dose- and time-dependent manner, as compared with untreated control cells. In parallel, DTCM-g treatment mediated a significant increase in apoptosis and arrest at the G1 stage of the cell cycle. Alternatively, DTCM-g failed to potentiate the cytotoxicity of the commonly used drugs in 3 of the ALL cell lines studied. Conclusion: Together the data reinforce the anticancer potential of DTCM-g although its applicability in polychemotherapeutic treatments deserves further investigation.Keywords: DTCM-g, leukemia, cell lines, drugs, chemotherapy, growth.
Graphical Abstract
Call for Papers in Thematic Issues
Bioactive Compounds as Promising Therapeutic Intervention for Central Nervous System Disorders: A Neuropharmacological Perspective
Bioactive compounds have gained tremendous attention due to their excellent health benefits in managing Central Nervous System (CNS) disorders, including depression, anxiety, neurodegeneration, epilepsy, and neurodevelopmental conditions. Due to limited therapeutic efficacy and significant side effects of existing treatments, it remains a global health challenge. They have emerged as viable ...read more
Bioactive Compounds: An Ideal Source for Drug Discovery, Design, Development and Target Identification
The Special Issue "Bioactive Compounds: Discovery, Design, Development, and Target Identification" aims to bring together innovative research and critical reviews on bioactive molecules that show therapeutic potential across diverse diseases. Discovery of novel bioactive compounds will focus on uncovering new molecules from natural or synthetic sources, expanding the library of ...read more
“Waste Fruit Peels and Plant Parts: Innovative Green Approach for Bioactives and Nanoparticle Synthesis”
The escalating demand for eco-friendly and sustainable nanotechnology has led to the exploration of innovative green approaches for nanoparticle synthesis. Among these, the utilization of waste fruit peels as bio-reductants and stabilizers has emerged as a promising, cost-effective, and environmentally benign strategy. Fruit peels, often discarded as waste, and are ...read more
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Analytical Chemistry
Current Computer-Aided Drug Design
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Cancer Therapy Reviews
Current Diabetes Reviews
Current Drug Safety
Current Drug Targets
Related Books
Zebrafish Models for Experimental Pharmacology: A Handbook
Bioactive Compounds Targeting Neurodegenerative Diseases
Anthraquinones: Bioactive Multifaceted Therapeutic Agents
Therapeutic Plants: Recent Advances in the Use of Herbs as Alternative Medications
Quality Assurance of Ethno-Herbals: Cultivating Confidence in Alternative Medicine
Ionic Liquids for Organic Synthesis
Traditional Medicine in North East Africa: Research on Traditional Healer Preparations and Herbs
Glycals and their Derivatives
Organic Spectroscopy Technology and Applications
Andrographolide and its Analogs: Botanical Sources, Phytochemistry, Pharmacology, and Biotechnology
23
1
